Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A. Ram Vachanaram"'
Autor:
Abdurraouf Mokhtar Mahmoud, Federica Biello, Paola Maria Maggiora, Riccardo Bruna, Giovanni Burrafato, Miriam Cappelli, Feba Varughese, Veronica Martini, Francesca Platini, Clara Deambrogi, Andrea Patriarca, Maura Nicolosi, Ajay ram Vachanaram, Carla Pisani, Eleonora Ferrara, Elvira Catania, Danila Azzolina, Francesco Barone-Adesi, Marco Krengli, Gianluca Gaidano, Alessandra Gennari
Publikováno v:
BMC Geriatrics, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Age is considered as one of the most important risk-factor for many types of solid and hematological cancers, as their incidence increases with age in parallel to the ever-growing elderly population. Moreover, cancer incidence is
Externí odkaz:
https://doaj.org/article/97ccbb1f1a4a4cc1b0e7fd54a253577c
Autor:
Simone Nardin, Edoardo Mora, Feba Mariam Varughese, Francesca D'Avanzo, Ajay Ram Vachanaram, Valentina Rossi, Chiara Saggia, Sara Rubinelli, Alessandra Gennari
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Breast cancer is the most frequent cancer in women: in 2018, almost two million cases have been diagnosed all over the world and it represents the principal cause of death from a neoplastic disease in women. In the past years, breast cancer prognosis
Externí odkaz:
https://doaj.org/article/576fa65c19a34e828476ab47011955ae
Autor:
Veronica Martini, Chiara Saggia, Francesca D'Avanzo, Valentina Rossi, Ivan Dodaro, Eleonora Gallarotti, Tania Pretato, Feba Mariam Varughese, Ajay Ram Vachanaram, Martina Cavalleri, Arianna Stella, Simone Gobbato, Andrea Tassone, Anna Gambaro, Carmen Branni, Paola Maria Maggiora, Alessia Rua, Renzo Boldorini, Eleonora Ferrara, Marco Krengli, Alessandra Gennari
Publikováno v:
Cancer Research. 82:P2-07
Background: Increasing evidence suggests a link between T-cell senescence and tumour prognosis. In particular, high levels of circulating senescent T-lymphocytes have been also correlated with a worse response to anti-cancer treatments. In this persp
Autor:
F. D'Avanzo, V. Rossi, C. Saggia, F. Platini, G. Borra, V. Martini, A. Rua, E. Gioffi, C. Branni, P.M. Maggiora, A. Tassone, F.M. Varughese, A. Ram Vachanaram, R. Ben Ayed, C. Angelillo, A. Barcellini, R. Boldorini, I. Dodaro, D. Ferrante, A. Gennari
Publikováno v:
Annals of Oncology. 33:S611
Autor:
Danila Azzolina, Elvira Catania, Ajay Ram Vachanaram, Paola Maria Maggiora, Maura Nicolosi, Clara Deambrogi, Riccardo Bruna, Giovanni Burrafato, Alessandra Gennari, Feba Varughese, Eleonora Ferrara, Marco Krengli, Miriam Cappelli, Veronica Martini, C. Pisani, Francesca Platini, Gianluca Gaidano, Federica Biello, Abdurraouf Mokhtar Mahmoud, Francesco Barone-Adesi, Andrea Patriarca
Publikováno v:
BMC Geriatrics
BMC Geriatrics, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Geriatrics, Vol 21, Iss 1, Pp 1-9 (2021)
BackgroundAge is considered as one of the most important risk-factor for many types of solid and hematological cancers, as their incidence increases with age in parallel to the ever-growing elderly population. Moreover, cancer incidence is constantly
Autor:
M. Cavalleri, Silvia Genestroni, Ajay Ram Vachanaram, Alessandra Gennari, F. Platini, Carlo Cattrini, David J. Pinato, C. Branni, A. Rua, Andrea Pietro Sponghini, Feba mariam Varughese, Alessia Mennitto, Daniela Ferrante, Veronica Martini, Paola Maria Maggiora, A. Gatti, Federica Biello, Antonio Sica, G. Borra
Publikováno v:
Annals of Oncology. 32:S1218
Autor:
D'Avanzo, F., Rossi, V., Saggia, C., Platini, F., Borra, G., Martini, V., Rua, A., Gioffi, E., Branni, C., Maggiora, P.M., Tassone, A., Varughese, F.M., Ram Vachanaram, A., Ben Ayed, R., Angelillo, C., Barcellini, A., Boldorini, R., Dodaro, I., Ferrante, D., Gennari, A.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S611-S611
Autor:
Silvia Genestroni, Ajay Ram Vachanaram, Veronica Martini, Simone Nardin, Guido Siffredi, Edoardo Mora, Feba mariam Varughese, Alessandra Gennari, Ilaria Repetti, Paolo Bruzzi, David J. Pinato, G. Borra, Federica Biello, Antonio Sica
Publikováno v:
Web of Science
e15263 Background: The introduction of immune check-point inhibitors (ICIs) in the treatment of a broad range of tumor types has led to a significant and clinically meaningful improvement in overall survival (OS) in advanced disease stages. However,